Why the study?
Does thrombolytic therapy improve coronary recanalization and reduce morbidity and mortality in patients with acute myocardial infarction?
Population
Patients with acute myocardial infarction
Design
Review
Authors
Loading...
Highlights thrombolysis benefits in AMI; leaves open need for updated RCTs versus modern reperfusion.
Does thrombolytic therapy improve coronary recanalization and reduce morbidity and mortality in patients with acute myocardial infarction?
Thrombolytic therapy, particularly intravenous tissue plasminogen activator, is an effective treatment for acute myocardial infarction that promotes coronary recanalization and reduces morbidity and mortality.
Zwerner et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: